Which white blood cell booster works best for breast cancer patients on chemo?
NCT ID NCT05296317
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 97 women with early-stage breast cancer who were getting strong chemotherapy. They were given one of two types of G-CSF (a drug that helps the body make more white blood cells) to see which one better prevented dangerously low white blood cell counts. The goal was to find the best way to keep patients safe during treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Georges François Leclerc (CGFL)
Dijon, Bourgogne-Franche-Comté, 21000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Common diabetes and acne drugs tested against cancer
- Can a simple protein test predict heart trouble in breast cancer patients?
- New radiation technique during breast surgery aims to reduce side effects for seniors
- Talking it out: study tests 'Remission' consultation for breast cancer patients
- Single-Dose radiation during breast surgery: a new hope?
- Cold war on baldness: which scalp cooling method wins for breast cancer patients?